• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名接受抗肿瘤坏死因子α(TNFα)治疗的川崎病患者的潜伏性结核感染治疗

Treatment of Latent Tuberculosis Infection in a Kawasaki Disease Patient Receiving Anti-Tumor Necrosis Factor Alpha (TNFα) Therapy.

作者信息

Yokoyama Koji, Yakuo Toshinari, Mamada Mitsukazu

机构信息

Pediatrics, Japanese Red Cross Wakayama Medical Center, Wakayama, JPN.

出版信息

Cureus. 2024 Sep 28;16(9):e70407. doi: 10.7759/cureus.70407. eCollection 2024 Sep.

DOI:10.7759/cureus.70407
PMID:39473638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11519388/
Abstract

Kawasaki disease (KD) is a common vasculitis syndrome that mainly affects children. Latent tuberculosis infection (LTBI) is a tuberculosis (TB) infection without signs or symptoms. Here, we report the case of a boy who traveled from abroad, was diagnosed with KD at our hospital, and underwent multidisciplinary treatment, including anti-TNFα therapy. Subsequently, the patient was found to have LTBI and was administered anti-TB treatment. To the best of our knowledge, this is the first reported case of LTBI in a KD patient receiving immunosuppressive therapy containing anti-TNFα.

摘要

川崎病(KD)是一种主要影响儿童的常见血管炎综合征。潜伏性结核感染(LTBI)是一种没有体征或症状的结核(TB)感染。在此,我们报告一例从国外前来就诊的男孩病例,该男孩在我院被诊断为川崎病,并接受了包括抗TNFα治疗在内的多学科治疗。随后,该患者被发现患有潜伏性结核感染,并接受了抗结核治疗。据我们所知,这是首例报道的在接受含抗TNFα免疫抑制治疗的川崎病患者中发生潜伏性结核感染的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/a9ec45a053a2/cureus-0016-00000070407-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/58457de8a4cb/cureus-0016-00000070407-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/9df182839b15/cureus-0016-00000070407-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/a9ec45a053a2/cureus-0016-00000070407-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/58457de8a4cb/cureus-0016-00000070407-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/9df182839b15/cureus-0016-00000070407-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1699/11519388/a9ec45a053a2/cureus-0016-00000070407-i03.jpg

相似文献

1
Treatment of Latent Tuberculosis Infection in a Kawasaki Disease Patient Receiving Anti-Tumor Necrosis Factor Alpha (TNFα) Therapy.一名接受抗肿瘤坏死因子α(TNFα)治疗的川崎病患者的潜伏性结核感染治疗
Cureus. 2024 Sep 28;16(9):e70407. doi: 10.7759/cureus.70407. eCollection 2024 Sep.
2
Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study.接受抗TNFα药物治疗的儿科患者中的结核病:一项队列研究。
Pediatr Rheumatol Online J. 2015 Dec 3;13:54. doi: 10.1186/s12969-015-0054-4.
3
Screening for acquired latent tuberculosis in rheumatoid arthritis patients on tumor necrosis factor inhibition therapy in Southern California.南加州肿瘤坏死因子抑制治疗的类风湿关节炎患者获得性潜伏性结核的筛查。
Clin Rheumatol. 2020 Aug;39(8):2291-2297. doi: 10.1007/s10067-020-04991-y. Epub 2020 Feb 28.
4
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.西班牙开展 TNF-α 抑制剂治疗前,应用结核菌素皮肤试验和 QuantiFERON-TB assays 进行潜伏性结核双重筛查。
Eur J Pediatr. 2023 Jan;182(1):307-317. doi: 10.1007/s00431-022-04640-3. Epub 2022 Nov 5.
5
[Biologics and mycobacterial diseases].[生物制剂与分枝杆菌病]
Kekkaku. 2013 Mar;88(3):337-53.
6
Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy.因开始使用抗肿瘤坏死因子疗法导致的炎症性肠病患者潜伏性结核感染的诊断与治疗
Intest Res. 2014 Jan;12(1):12-9. doi: 10.5217/ir.2014.12.1.12. Epub 2014 Jan 28.
7
Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study.抗肿瘤坏死因子-α 制剂治疗的儿童和青少年结核病:协作、多中心儿科结核病网络欧洲试验组(ptbnet)研究。
Clin Infect Dis. 2020 Dec 17;71(10):2561-2569. doi: 10.1093/cid/ciz1138.
8
Polymorphisms Are Genetic Markers for Vulnerability to Latent and Active Tuberculosis Infection in Taiwan.多态性是台湾潜伏性和活动性结核病易感性的遗传标志物。
Dis Markers. 2018 Dec 5;2018:4687380. doi: 10.1155/2018/4687380. eCollection 2018.
9
Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America.拉丁美洲流行地区治疗中炎症性肠病患者的活动性肺结核。
World J Gastroenterol. 2020 Nov 28;26(44):6993-7004. doi: 10.3748/wjg.v26.i44.6993.
10
The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers.接受肿瘤坏死因子-α阻滞剂治疗的韩国炎症性肠病患者患结核病的风险。
J Korean Med Sci. 2015 Feb;30(2):173-9. doi: 10.3346/jkms.2015.30.2.173. Epub 2015 Jan 21.

引用本文的文献

1
Indeterminate QuantiFERON Results in Pediatric Kawasaki Disease: Inflammatory Predictors and Diagnostic Implications.儿童川崎病中QuantiFERON检测结果不确定:炎症预测因素及诊断意义
Cureus. 2025 Jul 15;17(7):e88042. doi: 10.7759/cureus.88042. eCollection 2025 Jul.

本文引用的文献

1
Overview of Guidelines for the Medical Treatment of Acute Kawasaki Disease in Japan (2020 Revised Version) and Positioning of Plasma Exchange Therapy in the Acute Phase.日本急性川崎病医学治疗指南(2020修订版)概述及急性期血浆置换疗法的定位
Pediatr Infect Dis J. 2023 Sep 1;42(9):e328-e332. doi: 10.1097/INF.0000000000003974. Epub 2023 May 18.
2
Foreign Patients Visiting the Emergency Department: A Systematic Review of Studies in Japan.前往急诊科就诊的外国患者:日本研究的系统评价
JMA J. 2023 Apr 14;6(2):95-103. doi: 10.31662/jmaj.2022-0177. Epub 2023 Mar 13.
3
Management of Latent Tuberculosis Infection.
潜伏性结核感染的管理
JAMA. 2023 Feb 7;329(5):421-422. doi: 10.1001/jama.2022.24362.
4
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.西班牙开展 TNF-α 抑制剂治疗前,应用结核菌素皮肤试验和 QuantiFERON-TB assays 进行潜伏性结核双重筛查。
Eur J Pediatr. 2023 Jan;182(1):307-317. doi: 10.1007/s00431-022-04640-3. Epub 2022 Nov 5.
5
Coronary Artery Aneurysm in Kawasaki Disease: Coronary CT Angiography through the Lens of Pathophysiology and Differential Diagnosis.川崎病中的冠状动脉瘤:基于病理生理学和鉴别诊断视角的冠状动脉CT血管造影
Radiol Cardiothorac Imaging. 2021 Oct 28;3(5):e200550. doi: 10.1148/ryct.2021200550. eCollection 2021 Oct.
6
Communication challenges between nurses and migrant paediatric patients.护士与流动儿童患者之间的沟通挑战。
J Res Nurs. 2020 May;25(3):256-274. doi: 10.1177/1744987120909414. Epub 2020 May 3.
7
Preliminary Examination of an Appropriate Price Calculation Method and Medical Treatment Costs for Foreign Visitors in Japan.日本外国游客适当价格计算方法及医疗费用的初步考察。
Int J Environ Res Public Health. 2021 May 29;18(11):5837. doi: 10.3390/ijerph18115837.
8
Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.川崎病在 COVID-19 大流行前后的发病率:日本的一项回顾性队列研究。
BMJ Paediatr Open. 2021 Apr 2;5(1):e001034. doi: 10.1136/bmjpo-2021-001034. eCollection 2021.
9
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.在低传播环境中发现和验证新发结核病的个体化风险预测因子。
Nat Med. 2020 Dec;26(12):1941-1949. doi: 10.1038/s41591-020-1076-0. Epub 2020 Oct 19.
10
Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases.吸入性皮质类固醇与呼吸系统疾病患者结核病风险的关系。
Am J Respir Crit Care Med. 2011 Mar 1;183(5):675-8. doi: 10.1164/rccm.201007-1099OC. Epub 2010 Oct 1.